This might also explain our observed activation of all three UPR branches in metastatic compared to non-metastatic cells, while only the induction of the ATF6- and PERK-, but not the IRE1-pathway, is associated with poor survival in melanoma patients. This evidence concerns the gene EIF2AK3 and melanoma.